Press release
Asia-Pacific Anti-Inflammatory Therapeutics Market Set for Robust Growth: Projected to Hit $40.5 Billion by 2032
Asia-Pacific Anti-Inflammatory Therapeutics Market
The Asia-Pacific anti-inflammatory therapeutics market is experiencing significant growth, driven by rising cases of chronic inflammatory diseases, advancements in drug development, and increasing healthcare investments. Valued at $23.8 billion in 2022, the market is projected to reach $40.5 billion by 2032, growing at a CAGR of 5.4%.
Key Market Insights
What Are Anti-Inflammatory Therapeutics?
Anti-inflammatory drugs are medications designed to reduce inflammation caused by injuries, infections, or chronic conditions. They include:
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Block COX enzymes (e.g., ibuprofen, aspirin).
Corticosteroids: Reduce immune responses (e.g., prednisone).
Biologics: Target specific inflammatory pathways (e.g., TNF inhibitors like Humira).
Market Drivers
✔ Rising Prevalence of Inflammatory Diseases
Arthritis, psoriasis, asthma, and inflammatory bowel disease (IBD) are increasing in Asia-Pacific.
Japan reports a growing IBD incidence, while India sees a 1% rheumatoid arthritis prevalence.
✔ Strong R&D Investments & Drug Approvals
Sanofi, Takeda, and AbbVie have multiple drugs in clinical trials.
AbbVie's RINVOQ gained approval in Japan for psoriatic arthritis (2021).
Get a Sample Copy of this Report:
https://www.alliedmarketresearch.com/request-sample/1175
✔ Expansion of Biologic Drugs
SKYRIZI (AbbVie) and other biologics offer targeted therapy with fewer side effects.
✔ Growing Healthcare Infrastructure
Increased hospitalizations and retail pharmacy access boost drug availability.
Market Challenges
✖ Side Effects of Traditional Drugs
NSAIDs cause gastrointestinal bleeding and cardiovascular risks.
Long-term corticosteroid use leads to osteoporosis.
✖ Economic Slowdown Impact
Reduced pharmaceutical investments and delayed patient check-ups during recessions.
Market Segmentation
By Indication (2022 Dominance & Growth Trends)
Arthritis (Largest segment due to high rheumatoid arthritis cases)
Respiratory Diseases (Asthma, COPD)
Psoriasis (Growing biologics adoption)
Inflammatory Bowel Disease (IBD)
Multiple Sclerosis
Others
By Distribution Channel
Drug Stores & Retail Pharmacies (Leading segment due to OTC NSAID sales)
Hospital Pharmacies (High prescription demand)
Online Pharmacies (Fastest-growing with e-health trends)
By Country (Growth Hotspots)
China (Largest market, high patient pool)
Japan (Fastest growth, new drug approvals)
India (Rising arthritis & cancer-linked inflammation)
Australia & South Korea (Advanced healthcare systems)
Competitive Landscape
Key players are expanding through drug launches, approvals, and partnerships:
AbbVie Inc. (SKYRIZI, RINVOQ)
Pfizer Inc. (Celebrex, Xeljanz)
Novartis AG (Cosentyx)
Johnson & Johnson (Remicade, Stelara)
AstraZeneca (Fasenra for asthma)
Future Opportunities
🔹 Development of Safer, Targeted Therapies (Fewer side effects)
🔹 Expansion of Biosimilars (Cost-effective biologic alternatives)
🔹 Digital Health Integration (Telemedicine for chronic disease management)
Conclusion
The Asia-Pacific anti-inflammatory therapeutics market is set for robust growth, fueled by rising disease burden, innovative drug development, and improved healthcare access. While challenges like drug side effects and economic fluctuations persist, advancements in biologics and personalized medicine offer promising solutions.
Key Takeaways:
✅ $40.5 Billion Market by 2032 (5.4% CAGR)
✅ Arthritis Dominates due to high prevalence.
✅ Biologics & Biosimilars are game-changers.
✅ China & Japan Lead Growth in the region.
Enquire Before Buying: https://www.alliedmarketresearch.com/purchase-enquiry/1175
Contact Us:
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Int'l: +1-503-894-6022
Toll Free: +1-800-792-5285
Fax: +1-800-792-5285
help@alliedmarketresearch.com
About Us:
Allied Market Research is a top provider of market intelligence that offers reports from leading technology publishers. Our in-depth market assessments in our research reports take into account significant technological advancements in the sector. In addition to other areas of expertise, AMR focuses on the analysis of high-tech systems and advanced production systems. We have a team of experts who compile thorough research reports and actively advise leading businesses to enhance their current procedures. Our experts have a wealth of knowledge on the topics they cover. Also, they use a variety of tools and techniques when gathering and analyzing data, including patented data sources.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Asia-Pacific Anti-Inflammatory Therapeutics Market Set for Robust Growth: Projected to Hit $40.5 Billion by 2032 here
News-ID: 4037780 • Views: …
More Releases from allied market research
Air Ambulance Services Market Share to Reach $14.24 Billion by 2030
By service operator, the independent segment dominated the global air ambulance services market in 2020, in terms of revenue. On the basis of service type, the domestic segment garnered higher share in 2020. Depending on aircraft type, the fixed-wing segment held majority of the market share in 2020. Presently, North America is the highest revenue contributor, followed by Europe.
According to a recent report published by Allied Market Research, titled, "Air…
Defense IT spending Market Share to Reach $137.65 Billion by 2030
by system, the cybersecurity segment dominated the global defense IT spending market in 2020, in terms of revenue. By type, the services segment is anticipated to witness lucrative growth during the forecast period. By force, the defense forces segment dominated the defense IT spending market in 2020, in terms of revenue. Presently, North America is the highest revenue contributor, followed by Asia-Pacific.
According to a recent report published by Allied Market…
Ethernet Switch Market Size to Reach $26.1 Billion by 2031
The ethernet switch market share is expected to witness considerable growth, owing to rise in application of ethernet switch in industrial infrastructures, such as smart grid, intelligent rail & traffic, security & surveillance, and other utilities.
According to a new report published by Allied Market Research, titled, "Ethernet Switch Market By Type (Modular Ethernet Switches, Fixed Configuration Ethernet Switches), By Configuration (Unmanaged, Smart, Managed L2, Managed L3, Divided), By Speed (1G,…
3D Sensor Market Size to Reach $57 Billion by 2031
Increasing demand for 3D-enabled devices in consumer electronics and the rapid upsurge in the requirement for medical imaging solutions are propelling the growth of the 3D sensor market during the forecast period.
According to a new report published by Allied Market Research, titled, "3D Sensor Market," The 3d sensor market size was valued at $17.6 billion in 2021, and is estimated to reach $57 billion by 2031, growing at a…
More Releases for Inflammatory
Inflammatory Myositis Market Massive Growth opportunity Ahead
Introduction
Inflammatory myositis is a group of rare autoimmune disorders characterized by chronic inflammation of skeletal muscles, leading to progressive muscle weakness, fatigue, and functional disability. The spectrum includes polymyositis (PM), dermatomyositis (DM), inclusion body myositis (IBM), immune-mediated necrotizing myopathy (IMNM), and overlap syndromes. These disorders can also involve other organs, most notably the lungs (interstitial lung disease), skin, heart, and joints, complicating disease management.
Historically, corticosteroids and conventional immunosuppressants have formed…
Rising Incidence Of Inflammatory Bowel Disease Fuels Growth In The Anti-Inflamma …
The Anti-Inflammatory Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Anti-Inflammatory Therapeutics Market Size and Projected Growth Rate?
The market size of anti-inflammatory therapeutics has shown a consistent growth in the past few years. The market is projected to expand from $114.71…
Rising Incidence Of Inflammatory Bowel Disease Fuels Growth In The Anti-Inflamma …
What market dynamics are playing a key role in accelerating the growth of the anti-inflammatory therapeutics market?
As inflammatory bowel disease becomes more commonplace, it is predicted to encourage progress in the anti-inflammatory therapeutics market. Characterized as a long-term condition causing inflammation of the digestive tract, inflammatory bowel disease (IBD) is effectively managed with the usage of anti-inflammatory therapeutics. These treatments are central in the control of Crohn's disease via decreasing…
Anti-Inflammatory Activity Enzyme Manufacturer | Pearlzyme Inc
Pearlzyme Inc. is a South Korean company that manufactures anti inflammatory activity enzymes. This anti-inflammatory activity enzyme boosts the animal's immune system against infection and increases milk lactation.
Pearlzyme Inc. is committed to providing high-quality products and services to its customers. The company has a team of experienced scientists and engineers who are constantly working to develop new and innovative products. Pearlzyme Inc. is also committed to sustainable development and is…
Inflammatory Bowel Disease Market: The Present and Future of Inflammatory Bowel …
Stratagem Market Insights have included the latest addition of a global market research report titled Inflammatory Bowel Disease Market tits expansive repository. The report studies primary and secondary research in order to analyze the data effectively. The market study further draws attention to crucial industry factors such as global clients, potential customers, and sellers, which instigates positive company growth. In order to gauge the turning point of the businesses, significant…
Rising incidences of chronic inflammatory and autoimmune diseases has increased …
According to a new report published by apacmarket.com, titled, Anti-inflammatory Therapeutics Asia-Pacific Market Research Report, 2014-2020, the Asia-Pacific anti-inflammatory therapeutics market is expected to grow at a CAGR of 8.6% during the period of 2015-2020. The arthritis segment would continue to lead the Asia Pacific anti-inflammatory therapeutics market through 2020. China anti-inflammatory therapeutics market is forecast to grow at the highest CAGR of 13.9% during the forecast period.
Get the sample…
